327 related articles for article (PubMed ID: 17551402)
41. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
[TBL] [Abstract][Full Text] [Related]
42. Correlations Between MMPs and TIMPs Levels in Aqueous Humor from High Myopia and Cataract Patients.
Jia Y; Hu DN; Sun J; Zhou J
Curr Eye Res; 2017 Apr; 42(4):600-603. PubMed ID: 28402202
[TBL] [Abstract][Full Text] [Related]
43. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer.
Groblewska M; Siewko M; Mroczko B; Szmitkowski M
Folia Histochem Cytobiol; 2012 Apr; 50(1):12-9. PubMed ID: 22532131
[TBL] [Abstract][Full Text] [Related]
44. Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis.
Kong Y; Poon R; Nadesan P; Di Muccio T; Fodde R; Khokha R; Alman BA
Cancer Res; 2004 Aug; 64(16):5795-803. PubMed ID: 15313922
[TBL] [Abstract][Full Text] [Related]
45. [The expression of matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TIMPs) and angiogenesis in relation to the depth of tumor invasion and lymph node metastasis in submucosally invasive colorectal carcinoma].
Jung SA; Yang SK; Kim JS; Shim KN; Im SA; Myung SJ; Jung HY; Yu CS; Kim JC; Hong WS; Kim JH; Min YI
Korean J Gastroenterol; 2005 Jun; 45(6):401-8. PubMed ID: 15973074
[TBL] [Abstract][Full Text] [Related]
46. [The role of matrixmetalloproteinases in the tumor growth and metastasis].
Velinov N; Poptodorov G; Gabrovski N; Gabrovski S
Khirurgiia (Sofiia); 2010; (1):44-9. PubMed ID: 21972705
[TBL] [Abstract][Full Text] [Related]
47. Enhanced cell surface expression of matrix metalloproteinases and their inhibitors, and tumor-induced host response in progression of human gastric carcinoma.
Koyama S
Dig Dis Sci; 2004 Oct; 49(10):1621-30. PubMed ID: 15573916
[TBL] [Abstract][Full Text] [Related]
48. Dysregulation of immunoexpression of matrix metalloproteinases in renal chronic allograft injury.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2009; 60(2):88-93. PubMed ID: 19886183
[TBL] [Abstract][Full Text] [Related]
49. EMMPRIN-induced MMP-2 activation cascade in human cervical squamous cell carcinoma.
Sier CF; Zuidwijk K; Zijlmans HJ; Hanemaaijer R; Mulder-Stapel AA; Prins FA; Dreef EJ; Kenter GG; Fleuren GJ; Gorter A
Int J Cancer; 2006 Jun; 118(12):2991-8. PubMed ID: 16425263
[TBL] [Abstract][Full Text] [Related]
50. Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma.
Korpi JT; Hagström J; Lehtonen N; Parkkinen J; Sorsa T; Salo T; Laitinen M
Surg Oncol; 2011 Mar; 20(1):e18-22. PubMed ID: 20880700
[TBL] [Abstract][Full Text] [Related]
51. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis.
Fielitz J; Leuschner M; Zurbrügg HR; Hannack B; Pregla R; Hetzer R; Regitz-Zagrosek V
J Mol Med (Berl); 2004 Dec; 82(12):809-20. PubMed ID: 15558223
[TBL] [Abstract][Full Text] [Related]
52. Extracellular matrix metalloproteinase inducer (EMMPRIN) remodels the extracellular matrix through enhancing matrix metalloproteinases (MMPs) and inhibiting tissue inhibitors of MMPs expression in HPV-positive cervical cancer cells.
Xu Q; Cao X; Pan J; Ye Y; Xie Y; Ohara N; Ji H
Eur J Gynaecol Oncol; 2015; 36(5):539-45. PubMed ID: 26513879
[TBL] [Abstract][Full Text] [Related]
53. Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human glioblastoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2014 Aug; 45(2):887-94. PubMed ID: 24867464
[TBL] [Abstract][Full Text] [Related]
54. [Expression and significance of matrix metalloproteinases and their tissue inhibitors in the infiltration and metastasis of lung cancer].
Wang X; Yang J; Ma Y; Zheng H; Cheng B; Zheng H; Zhu C
Zhongguo Fei Ai Za Zhi; 2003 Aug; 6(4):278-82. PubMed ID: 21272482
[TBL] [Abstract][Full Text] [Related]
55. Matrix metalloproteinases and their inhibitors in exfoliation syndrome.
Gartaganis SP; Georgakopoulos CD; Mela EK; Exarchou A; Ziouti N; Assouti M; Vynios DH
Ophthalmic Res; 2002; 34(3):165-71. PubMed ID: 12097800
[TBL] [Abstract][Full Text] [Related]
56. [The role of selected matrix metalloproteinases and their inhibitors in colorectal cancer development].
Groblewska M; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw (Online); 2010 Jan; 64():22-30. PubMed ID: 20173217
[TBL] [Abstract][Full Text] [Related]
57. [Relationship of the disturbed balance between matrix metalloproteinases and their tissue inhibitors and the invasion of malignant salivary gland tumours].
Tian K; Chen Y; Geng N; Yang MZ; Zhang WP
Hua Xi Kou Qiang Yi Xue Za Zhi; 2005 Aug; 23(4):273-6, 279. PubMed ID: 16178181
[TBL] [Abstract][Full Text] [Related]
58. Angelica sinensis suppresses human lung adenocarcinoma A549 cell metastasis by regulating MMPs/TIMPs and TGF-β1.
Gao M; Zhang JH; Zhou FX; Xie CH; Han G; Fang SQ; Zhou YF
Oncol Rep; 2012 Feb; 27(2):585-93. PubMed ID: 22076386
[TBL] [Abstract][Full Text] [Related]
59. Matrix metalloproteinases in colorectal cancer.
Mysliwiec AG; Ornstein DL
Clin Colorectal Cancer; 2002 Feb; 1(4):208-19. PubMed ID: 12450419
[TBL] [Abstract][Full Text] [Related]
60. The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformis.
Zebrowska A; Narbutt J; Sysa-Jedrzejowska A; Kobos J; Waszczykowska E
Mediators Inflamm; 2005 Dec; 2005(6):373-9. PubMed ID: 16489258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
